img

Global and United States Horse Vaccines Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Horse Vaccines Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Horse Vaccines Market
This report focuses on global and United States Horse Vaccines market, also covers the segmentation data of other regions in regional level and county level.
The global Horse Vaccines revenue was US$ 652 million in 2024 and is forecast to a readjusted size of US$ 937.8 million by 2034 with a CAGR of 5.4% during the forecast period (2024-2034).
In United States the Horse Vaccines revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Horse Vaccines include Merck Animal Health, Boehringer Ingelheim, Zoetis, Colorado Serum, VetOne, Neogen, Wuhan Chopper Biology Co., Ltd. and Intervacc AB, etc. The global five biggest players hold a share of % in 2024.
Global Horse Vaccines Scope and Market Size
Horse Vaccines market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Horse Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Horse Vaccines market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Merck Animal Health
Boehringer Ingelheim
Zoetis
Colorado Serum
VetOne
Neogen
Wuhan Chopper Biology Co., Ltd.
Intervacc AB
Segment by Type
Rabies Vaccine
Eastern and Western Equine Encephalomyelitis (EEE/WEE) Vaccine
Tetanus Vaccine
West Nile Virus (WNV) Vaccine
Others

Segment by Application


Adult Horse(>12 Months)
Young Horse(≤12 Months)
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Horse Vaccines definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Horse Vaccines companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Horse Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Horse Vaccines sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Horse Vaccines Product Introduction
1.2 Global Horse Vaccines Outlook 2018 VS 2024 VS 2034
1.2.1 Global Horse Vaccines Sales in US$ Million for the Year 2018-2034
1.2.2 Global Horse Vaccines Sales in Volume for the Year 2018-2034
1.3 United States Horse Vaccines Outlook 2018 VS 2024 VS 2034
1.3.1 United States Horse Vaccines Sales in US$ Million for the Year 2018-2034
1.3.2 United States Horse Vaccines Sales in Volume for the Year 2018-2034
1.4 Horse Vaccines Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Horse Vaccines in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Horse Vaccines Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Horse Vaccines Market Dynamics
1.5.1 Horse Vaccines Industry Trends
1.5.2 Horse Vaccines Market Drivers
1.5.3 Horse Vaccines Market Challenges
1.5.4 Horse Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Horse Vaccines by Type
2.1 Horse Vaccines Market Segment by Type
2.1.1 Rabies Vaccine
2.1.2 Eastern and Western Equine Encephalomyelitis (EEE/WEE) Vaccine
2.1.3 Tetanus Vaccine
2.1.4 West Nile Virus (WNV) Vaccine
2.1.5 Others
2.2 Global Horse Vaccines Market Size by Type
2.2.1 Global Horse Vaccines Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Horse Vaccines Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Horse Vaccines Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Horse Vaccines Market Size by Type
2.3.1 United States Horse Vaccines Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Horse Vaccines Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Horse Vaccines Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Horse Vaccines by Application
3.1 Horse Vaccines Market Segment by Application
3.1.1 Adult Horse(>12 Months)
3.1.2 Young Horse(≤12 Months)
3.2 Global Horse Vaccines Market Size by Application
3.2.1 Global Horse Vaccines Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Horse Vaccines Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Horse Vaccines Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Horse Vaccines Market Size by Application
3.3.1 United States Horse Vaccines Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Horse Vaccines Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Horse Vaccines Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Horse Vaccines Competitor Landscape by Company
4.1 Global Horse Vaccines Market Size by Company
4.1.1 Global Key Manufacturers of Horse Vaccines, Ranked by Revenue (2024)
4.1.2 Global Horse Vaccines Revenue by Manufacturer (2018-2023)
4.1.3 Global Horse Vaccines Sales by Manufacturer (2018-2023)
4.1.4 Global Horse Vaccines Price by Manufacturer (2018-2023)
4.2 Global Horse Vaccines Concentration Ratio (CR)
4.2.1 Horse Vaccines Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Horse Vaccines in 2024
4.2.3 Global Horse Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Horse Vaccines, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Horse Vaccines, Product Offered and Application
4.5 Global Key Manufacturers of Horse Vaccines, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Horse Vaccines Market Size by Company
4.7.1 Key Players of Horse Vaccines in United States, Ranked by Revenue (2024)
4.7.2 United States Horse Vaccines Revenue by Players (2018-2023)
4.7.3 United States Horse Vaccines Sales by Players (2018-2023)
5 Global Horse Vaccines Market Size by Region
5.1 Global Horse Vaccines Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Horse Vaccines Market Size in Volume by Region (2018-2034)
5.2.1 Global Horse Vaccines Sales in Volume by Region: 2018-2023
5.2.2 Global Horse Vaccines Sales in Volume Forecast by Region (2024-2034)
5.3 Global Horse Vaccines Market Size in Value by Region (2018-2034)
5.3.1 Global Horse Vaccines Sales in Value by Region: 2018-2023
5.3.2 Global Horse Vaccines Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Horse Vaccines Market Size YoY Growth 2018-2034
6.2 Americas Horse Vaccines Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Horse Vaccines Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Horse Vaccines Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Horse Vaccines Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Horse Vaccines Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Horse Vaccines Market Size YoY Growth 2018-2034
7.2 EMEA Horse Vaccines Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Horse Vaccines Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Horse Vaccines Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Horse Vaccines Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Horse Vaccines Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Horse Vaccines Market Size YoY Growth 2018-2034
8.2 China Horse Vaccines Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Horse Vaccines Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Horse Vaccines Market Size YoY Growth 2018-2034
9.2 APAC Horse Vaccines Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Horse Vaccines Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Horse Vaccines Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Horse Vaccines Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Horse Vaccines Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Merck Animal Health
10.1.1 Merck Animal Health Company Information
10.1.2 Merck Animal Health Description and Business Overview
10.1.3 Merck Animal Health Horse Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Animal Health Horse Vaccines Products Offered
10.1.5 Merck Animal Health Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Description and Business Overview
10.2.3 Boehringer Ingelheim Horse Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Horse Vaccines Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 Zoetis
10.3.1 Zoetis Company Information
10.3.2 Zoetis Description and Business Overview
10.3.3 Zoetis Horse Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Zoetis Horse Vaccines Products Offered
10.3.5 Zoetis Recent Development
10.4 Colorado Serum
10.4.1 Colorado Serum Company Information
10.4.2 Colorado Serum Description and Business Overview
10.4.3 Colorado Serum Horse Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Colorado Serum Horse Vaccines Products Offered
10.4.5 Colorado Serum Recent Development
10.5 VetOne
10.5.1 VetOne Company Information
10.5.2 VetOne Description and Business Overview
10.5.3 VetOne Horse Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 VetOne Horse Vaccines Products Offered
10.5.5 VetOne Recent Development
10.6 Neogen
10.6.1 Neogen Company Information
10.6.2 Neogen Description and Business Overview
10.6.3 Neogen Horse Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Neogen Horse Vaccines Products Offered
10.6.5 Neogen Recent Development
10.7 Wuhan Chopper Biology Co., Ltd.
10.7.1 Wuhan Chopper Biology Co., Ltd. Company Information
10.7.2 Wuhan Chopper Biology Co., Ltd. Description and Business Overview
10.7.3 Wuhan Chopper Biology Co., Ltd. Horse Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Wuhan Chopper Biology Co., Ltd. Horse Vaccines Products Offered
10.7.5 Wuhan Chopper Biology Co., Ltd. Recent Development
10.8 Intervacc AB
10.8.1 Intervacc AB Company Information
10.8.2 Intervacc AB Description and Business Overview
10.8.3 Intervacc AB Horse Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Intervacc AB Horse Vaccines Products Offered
10.8.5 Intervacc AB Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Horse Vaccines Industry Chain Analysis
11.2 Horse Vaccines Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Horse Vaccines Production Mode & Process
11.4 Horse Vaccines Sales and Marketing
11.4.1 Horse Vaccines Sales Channels
11.4.2 Horse Vaccines Distributors
11.5 Horse Vaccines Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Horse Vaccines CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Horse Vaccines Market Trends
Table 3. Horse Vaccines Market Drivers
Table 4. Horse Vaccines Market Challenges
Table 5. Horse Vaccines Market Restraints
Table 6. Global Horse Vaccines Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Horse Vaccines Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Horse Vaccines Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Horse Vaccines Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Horse Vaccines, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Horse Vaccines Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Horse Vaccines Revenue Share by Manufacturer, 2018-2023
Table 13. Global Horse Vaccines Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Horse Vaccines Sales Share by Manufacturer, 2018-2023
Table 15. Global Horse Vaccines Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Horse Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Horse Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Horse Vaccines as of 2024)
Table 18. Global Key Manufacturers of Horse Vaccines, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Horse Vaccines, Product Offered and Application
Table 20. Global Key Manufacturers of Horse Vaccines, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Horse Vaccines in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Horse Vaccines Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Horse Vaccines Revenue Share by Players, (2018-2023)
Table 25. United States Horse Vaccines Sales by Players, (K Units), (2018-2023)
Table 26. United States Horse Vaccines Sales Share by Players, (2018-2023)
Table 27. Global Horse Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Horse Vaccines Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Horse Vaccines Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Horse Vaccines Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Horse Vaccines Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Horse Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Horse Vaccines Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Horse Vaccines Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Horse Vaccines Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Horse Vaccines Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Horse Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Horse Vaccines Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Horse Vaccines Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Horse Vaccines Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Horse Vaccines Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Horse Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Horse Vaccines Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Horse Vaccines Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Horse Vaccines Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Horse Vaccines Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Merck Animal Health Company Information
Table 48. Merck Animal Health Description and Business Overview
Table 49. Merck Animal Health Horse Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Merck Animal Health Horse Vaccines Product
Table 51. Merck Animal Health Recent Development
Table 52. Boehringer Ingelheim Company Information
Table 53. Boehringer Ingelheim Description and Business Overview
Table 54. Boehringer Ingelheim Horse Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Boehringer Ingelheim Horse Vaccines Product
Table 56. Boehringer Ingelheim Recent Development
Table 57. Zoetis Company Information
Table 58. Zoetis Description and Business Overview
Table 59. Zoetis Horse Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Zoetis Horse Vaccines Product
Table 61. Zoetis Recent Development
Table 62. Colorado Serum Company Information
Table 63. Colorado Serum Description and Business Overview
Table 64. Colorado Serum Horse Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Colorado Serum Horse Vaccines Product
Table 66. Colorado Serum Recent Development
Table 67. VetOne Company Information
Table 68. VetOne Description and Business Overview
Table 69. VetOne Horse Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. VetOne Horse Vaccines Product
Table 71. VetOne Recent Development
Table 72. Neogen Company Information
Table 73. Neogen Description and Business Overview
Table 74. Neogen Horse Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Neogen Horse Vaccines Product
Table 76. Neogen Recent Development
Table 77. Wuhan Chopper Biology Co., Ltd. Company Information
Table 78. Wuhan Chopper Biology Co., Ltd. Description and Business Overview
Table 79. Wuhan Chopper Biology Co., Ltd. Horse Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Wuhan Chopper Biology Co., Ltd. Horse Vaccines Product
Table 81. Wuhan Chopper Biology Co., Ltd. Recent Development
Table 82. Intervacc AB Company Information
Table 83. Intervacc AB Description and Business Overview
Table 84. Intervacc AB Horse Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Intervacc AB Horse Vaccines Product
Table 86. Intervacc AB Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Horse Vaccines Customers List
Table 90. Horse Vaccines Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Horse Vaccines Product Picture
Figure 2. Global Horse Vaccines Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Horse Vaccines Market Size 2018-2034 (US$ Million)
Figure 4. Global Horse Vaccines Sales 2018-2034 (K Units)
Figure 5. United States Horse Vaccines Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Horse Vaccines Market Size 2018-2034 (US$ Million)
Figure 7. United States Horse Vaccines Sales 2018-2034 (K Units)
Figure 8. United States Horse Vaccines Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Horse Vaccines Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Horse Vaccines Report Years Considered
Figure 11. Product Picture of Rabies Vaccine
Figure 12. Product Picture of Eastern and Western Equine Encephalomyelitis (EEE/WEE) Vaccine
Figure 13. Product Picture of Tetanus Vaccine
Figure 14. Product Picture of West Nile Virus (WNV) Vaccine
Figure 15. Product Picture of Others
Figure 16. Global Horse Vaccines Market Share by Type in 2024 & 2034
Figure 17. Global Horse Vaccines Sales in Value by Type (2018-2034) & (US$ Million)
Figure 18. Global Horse Vaccines Sales Market Share in Value by Type (2018-2034)
Figure 19. Global Horse Vaccines Sales by Type (2018-2034) & (K Units)
Figure 20. Global Horse Vaccines Sales Market Share in Volume by Type (2018-2034)
Figure 21. Global Horse Vaccines Price by Type (2018-2034) & (US$/Unit)
Figure 22. United States Horse Vaccines Market Share by Type in 2024 & 2034
Figure 23. United States Horse Vaccines Sales in Value by Type (2018-2034) & (US$ Million)
Figure 24. United States Horse Vaccines Sales Market Share in Value by Type (2018-2034)
Figure 25. United States Horse Vaccines Sales by Type (2018-2034) & (K Units)
Figure 26. United States Horse Vaccines Sales Market Share in Volume by Type (2018-2034)
Figure 27. United States Horse Vaccines Price by Type (2018-2034) & (US$/Unit)
Figure 28. Product Picture of Adult Horse(>12 Months)
Figure 29. Product Picture of Young Horse(≤12 Months)
Figure 30. Global Horse Vaccines Market Share by Application in 2024 & 2034
Figure 31. Global Horse Vaccines Sales in Value by Application (2018-2034) & (US$ Million)
Figure 32. Global Horse Vaccines Sales Market Share in Value by Application (2018-2034)
Figure 33. Global Horse Vaccines Sales by Application (2018-2034) & (K Units)
Figure 34. Global Horse Vaccines Sales Market Share in Volume by Application (2018-2034)
Figure 35. Global Horse Vaccines Price by Application (2018-2034) & (US$/Unit)
Figure 36. United States Horse Vaccines Market Share by Application in 2024 & 2034
Figure 37. United States Horse Vaccines Sales in Value by Application (2018-2034) & (US$ Million)
Figure 38. United States Horse Vaccines Sales Market Share in Value by Application (2018-2034)
Figure 39. United States Horse Vaccines Sales by Application (2018-2034) & (K Units)
Figure 40. United States Horse Vaccines Sales Market Share in Volume by Application (2018-2034)
Figure 41. United States Horse Vaccines Price by Application (2018-2034) & (US$/Unit)
Figure 42. Americas Horse Vaccines Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 43. Americas Horse Vaccines Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 44. Americas Horse Vaccines Sales by Type (2018-2034) & (K Units)
Figure 45. Americas Horse Vaccines Sales Market Share in Volume by Type (2018-2034)
Figure 46. Americas Horse Vaccines Sales by Application (2018-2034) & (K Units)
Figure 47. Americas Horse Vaccines Sales Market Share in Volume by Application (2018-2034)
Figure 48. United States Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Canada Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Mexico Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. EMEA Horse Vaccines Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 53. EMEA Horse Vaccines Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 54. EMEA Horse Vaccines Sales by Type (2018-2034) & (K Units)
Figure 55. EMEA Horse Vaccines Sales Market Share in Volume by Type (2018-2034)
Figure 56. EMEA Horse Vaccines Sales by Application (2018-2034) & (K Units)
Figure 57. EMEA Horse Vaccines Sales Market Share in Volume by Application (2018-2034)
Figure 58. Europe Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. Middle East Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Africa Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. China Horse Vaccines Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 62. China Horse Vaccines Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 63. China Horse Vaccines Sales by Type (2018-2034) & (K Units)
Figure 64. China Horse Vaccines Sales Market Share in Volume by Type (2018-2034)
Figure 65. China Horse Vaccines Sales by Application (2018-2034) & (K Units)
Figure 66. China Horse Vaccines Sales Market Share in Volume by Application (2018-2034)
Figure 67. APAC Horse Vaccines Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 68. APAC Horse Vaccines Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 69. APAC Horse Vaccines Sales by Type (2018-2034) & (K Units)
Figure 70. APAC Horse Vaccines Sales Market Share in Volume by Type (2018-2034)
Figure 71. APAC Horse Vaccines Sales by Application (2018-2034) & (K Units)
Figure 72. APAC Horse Vaccines Sales Market Share in Volume by Application (2018-2034)
Figure 73. Japan Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. South Korea Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. China Taiwan Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. India Horse Vaccines Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. Horse Vaccines Value Chain
Figure 79. Horse Vaccines Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed